1,002
Views
0
CrossRef citations to date
0
Altmetric
Immune Cytopenia

Human platelet antigen 1, 2 and 5 gene polymorphisms in Egyptians and their potential association with susceptibility to immune thrombocytopenic purpura in Egyptian patients

, , &

References

  • Pavkovic M, Stojanovic A, Karanfilski O, et al. Association of polymorphisms in human platelet antigens with idiopathic thrombocytopenic purpura in Macedonians. Prilozi. 2012;33(1):135–146.
  • Shaiegan M, Samiei S, Ataee Z, et al. Frequency of human platelet antigens (HPA-2/3/5) polymorphism in Iranians evaluated by RFLP-PCR. IJBC. 2011;3:101–105.
  • Curtis BR. Genotyping for human platelet alloantigen polymorphisms: applications in the diagnosis of alloimmune platelet disorders. Semin Thromb Hemost. 2008;34:539–548. doi: 10.1055/s-0028-1103365
  • Holensteiner A, Walchshofer S, Adler A, et al. Human platelet antigen gene frequencies in the Austrian population. Haemostasis. 1995;25:133–136.
  • Kim HO, Jin Y, Kickler TS, et al. Gene frequencies of the five major human platelet antigens in African American, white, and Korean populations. Transfusion. 1995;35:863–867. doi: 10.1046/j.1537-2995.1995.351096026369.x
  • Seo DH, Park SS, Kim DW, et al. Gene frequencies of eight human platelet-specific antigens in Koreans. Transfus Med. 1998;8:129–132. doi: 10.1046/j.1365-3148.1998.00138.x
  • Neunert C, Lim W, Crowther M, et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011;117:4190–4207. doi: 10.1182/blood-2010-08-302984
  • Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386–2393. doi: 10.1182/blood-2008-07-162503
  • Zhou Z, Chen Z, Li H, et al. BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura. Autoimmunity. 2009;42:112–119. doi: 10.1080/08916930802397848
  • Fratellanza G, Scarpato N, D’Agostino E, et al. Genomic restriction fragment length polymorphism typing of human platelet-specific antigens in blood donors from southern Italy and in alloimmunised pregnancies. Blood Transfus. 2005;3:222–230.
  • Salem AH, Han K, Batzer MA. Allele frequencies of the human platelet antigen-1 in the Egyptian population. BMC Res Notes. 2009;2(1):90. doi: 10.1186/1756-0500-2-90
  • Husebekk A, El Ekiaby M, Gorgy G, et al. Foetal/neonatal alloimmune thrombocytopenia in Egypt; human platelet antigen genotype frequencies and antibody detection and follow-up in pregnancies. Transfus Apher Sci. 2012;47(3):277–282. doi: 10.1016/j.transci.2012.04.001
  • Salem AH, Abdel Hamed AE, Abdalla EM, et al. Gene frequencies of human platelet alloantigens 1–5 in two Arab populations. Blood Transfus. 2014;12(1):281.
  • Kim BS, Song KS. Genetic polymorphism of human platelet specific antigen (HPA) in patients with immune thrombocytopenia. Thromb Haemost. 1997:1037.
  • Castro V, Oliveira GB, Origa AF, et al. The human platelet alloantigen 5 polymorphism as a risk for the development of acute idiopathic thrombocytopenia purpura. Thromb Haemost. 2000;84(2):360–361.
  • Thude H, Gatzka E, Anders O, et al. Allele frequencies of human platelet antigen 1, 2, 3, and 5 systems in patients with chronic refractory autoimmune thrombocytopenia and in normal persons. Vox Sang. 1999;77(3):149–153. doi: 10.1046/j.1423-0410.1999.7730149.x
  • Al-Subaie AM, Al-Absi IK, Al-Ola K, et al. Gene frequencies of human platelet alloantigens in Bahraini Arabs. Am J Hematol. 2007;82(3):242–244. doi: 10.1002/ajh.20769
  • Ferrer G, Muñiz-Diaz E, Aluja MP, et al. Analysis of human platelet antigen systems in a Moroccan Berber population. Transfus Med. 2002;12(1):49–54. doi: 10.1046/j.1365-3148.2002.00349.x
  • Brouk H, Halle L, Bertrand G, et al. Human platelet antigen allele frequencies in different Algerian populations. Tissue Antigens. 2010;75(6):673–678. doi: 10.1111/j.1399-0039.2009.01429.x
  • Mojaat N, Halle L, Proulle V, et al. Gene frequencies of human platelet antigens in the Tunisian population. Tissue Antigens. 1999;54(2):201–204. doi: 10.1034/j.1399-0039.1999.540214.x
  • Al-Ouda SK, Al-Banyan AA, Abdel Gader AGM, et al. Gene frequency of human platelet alloantigens-1 to -6 and -15 in Saudi blood donors. Transfus Med. 2016;26(3):220–224. doi: 10.1111/tme.12297
  • Mazzucco L, Santi R, Contino L. “HPA-1/6 allelomorphism study in juvenile stroke: the possible role of HPA-2b and HPA-5b.” 6th European Symposium on Platelet, Granulocyte and Red Cell Immunobiology (Abstract book). Amsterdam; 2000.
  • Pavkovic M, Petlichkovski A, Strezova A, et al. Gene frequencies of human platelet antigens in the Macedonian population. Tissue Antigens. 2006;67(3):241–246. doi: 10.1111/j.1399-0039.2006.00551.x
  • Muñiz-Díaz E, Arilla M, Ibáñez M, et al. Frequency of platelet alloantigens in the Spanish population. Sangre (Barc). 1993;38(4):289–293.
  • Rozman P, Drabbels J, Schipper RF, et al. Genotyping for human platelet-specific antigens HPA-1, -2, -3, -4 and -5 in the Slovenian population reveals a slightly increased frequency of HPA-1b and HPA-2b as compared to other European populations. Eur J Immunogenet. 1999;26(4):265–269. doi: 10.1046/j.1365-2370.1999.00142.x
  • Drzewek K, Brojer E, Zupańska B. The frequency of human platelet antigen (HPA) genotypes in the Polish population. Transfus Med. 1998;8(4):339–342. doi: 10.1046/j.1365-3148.1998.00164.x
  • Randen I, Sørensen K, Killie MK, et al. Rapid and reliable genotyping of human platelet antigen (HPA)-1, -2, -3, -4, and -5 a/b and Gov a/b by melting curve analysis. Transfusion. 2003;43(4):445–450. doi: 10.1046/j.1537-2995.2003.00354.x
  • Boehlen F, Bulla O, Michel M, et al. HPA-genotyping and antiplatelet antibodies in female blood donors. Hematol J. 2003;4(6):441–444. doi: 10.1038/sj.thj.6200338
  • Jones DC, Bunce M, Fuggle S V, et al. Human platelet alloantigens (HPAs): PCR-SSP genotyping of a UK population for 15 HPA alleles. Eur J Immunogenet. 2003;30(6):415–419. doi: 10.1111/j.1365-2370.2003.00426.x
  • Carlsson LE, Greinacher A, Spitzer C, et al. Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/ IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke. Stroke. 1997;28:1392–1395. doi: 10.1161/01.STR.28.7.1392
  • Halle L, Bigot A, Mulen-Imandy G, et al. HPA polymorphism in sub-Saharan African populations: Beninese, Cameroonians, Congolese, and Pygmies. Tissue Antigens. 2005;65(3):295–298. doi: 10.1111/j.1399-0039.2005.00360.x
  • De La Vega Elena CD, Nogues N, Fernandez Montoya A, et al. Human platelet-specific antigens frequencies in the Argentinean population. Transfus Med. 2008;18(2):83–90. doi: 10.1111/j.1365-3148.2007.00819.x
  • Castro V, Origa AF, Annichino-Bizzacchi JM, et al. Frequencies of platelet-specific alloantigen systems 1–5 in three distinct ethnic groups in Brazil. Eur J Immunogenet. 1999;26(5):355–360. doi: 10.1046/j.1365-2370.1999.00174.x
  • Bhatti FA, Uddin M, Ahmed A, et al. Human platelet antigen polymorphisms (HPA-1, -2, -3, -4, -5 and -15) in major ethnic groups of Pakistan. Transfus Med. 2010;20(2):78–87. doi: 10.1111/j.1365-3148.2009.00982.x
  • Feng ML, Liu DZ, Shen W, et al. Establishment of an HPA-1- to -16-typed platelet donor registry in China. Transfus Med. 2006;16(5):369–374. doi: 10.1111/j.1365-3148.2006.00687.x
  • Matsuzaki T, Nomura S, Yamaoka M, et al. HLA and HPA typing in idiopathic thrombocytopenic purpura patients treated with Kami-kihi-to. Am J Chin Med. 1998;26(2):191–198. doi: 10.1142/S0192415X98000245
  • Nomura S, Matsuzaki T, Yamaoka M, et al. Genetic analysis of HLA- and HPA-typing in idiopathic (autoimmune) thrombocytopenic purpura patients treated with cepharanthin. Autoimmunity. 1999;30(2):99–105. doi: 10.3109/08916939908994767

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.